4//SEC Filing
Egholm Michael 4
Accession 0000950170-25-052047
CIK 0001162194other
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:04 PM ET
Size
8.7 KB
Accession
0000950170-25-052047
Insider Transaction Report
Form 4
Egholm Michael
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-04-04−196,512→ 196,513 total→ Common Stock (196,512 underlying) - Exercise/Conversion
Common Stock
2025-04-04+196,512→ 2,832,518 total - Tax Payment
Common Stock
2025-04-04$1.07/sh−57,676$61,713→ 2,774,842 total
Footnotes (3)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
- [F2]Each RSU represents the contingent right to receive one share of the Issuer's common stock.
- [F3]On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023.
Documents
Issuer
STANDARD BIOTOOLS INC.
CIK 0001162194
Entity typeother
Related Parties
1- filerCIK 0001559779
Filing Metadata
- Form type
- 4
- Filed
- Apr 7, 8:00 PM ET
- Accepted
- Apr 8, 4:04 PM ET
- Size
- 8.7 KB